Frequently Asked Questions
The market is segmented based on Global Age-Related Macular Degeneration (AMD) Disease - Anti VEGF Market, By Type (Dry AMD and Wet AMD), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others), Distribution Channel (Direct Tender and Retail Sales) - Industry Trends and Forecast to 2031.
.
The Global Age Related Macular Degeneration Amd Disease Anti Vegf Market size was valued at USD 13677.02 USD Million in 2021.
The Global Age Related Macular Degeneration Amd Disease Anti Vegf Market is projected to grow at a CAGR of 6.8% during the forecast period of 2022 to 2029.
The major players operating in the market include Regeneron Pharmaceuticals, Biogen, Outlook Therapeutics, Sulentis, Novartis, Genentech, Bayer, Adverum Biotechnologies, Gensight Biologics, REGENXBIO, OCUGEN, MeiraGTX, Johnson & Johnson Services, IVERIC bio, KODIAK SCIENCES, Ionis Pharmaceuticals.
The market report covers data from the U.S., Canada, Mexico, Germany, France, Italy U.K., Spain, Russia, Austria, Netherlands, Hungary, Poland, Switzerland, Turkey, Norway, Lithuania, Ireland, Rest of Europe, Japan, China, India, Australia, Singapore, South Korea, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Egypt, Saudi Arabia, Israel, U.A.E., Kuwait, and Rest of Middle East and Africa.
